Skip Nav Destination

Issues

Select Year

Issue

Volume 5, Issue 11

1 November 1999

All Issues

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Editorials
Advances in Brief
Clinical Trials
Molecular Oncology, Markers, Clinical Correlates
Experimental Therapeutics, Preclinical Pharmacology
Cancer Biology, Immunology, Cytokines
Letters to the Editor

Editorials

p53 Prognostication: Paradigm or Paradox?

Jack A. Roth

Extract

View article

PDF

Drug Resistance: Still on the Learning Curve

Susan E. Bates

Extract

View article

PDF

Intrathecal Depot Cytarabine Therapy: A Welcome Addition to a Limited Armamentarium

W. Archie Bleyer

Extract

View article

PDF

Advances in Brief

Rapid Activation of MDR1 Gene Expression in Human Metastatic Sarcoma after in Vivo Exposure to Doxorubicin 1

Amir Abolhoda; Amy E. Wilson; Howard Ross; Peter V. Danenberg; Michael Burt; Kathleen W. Scotto

Abstract

View article

PDF

Phase I Study of an Antisense Oligonucleotide to Protein Kinase C-α (ISIS 3521/CGP 64128A 1) in Patients with Cancer²

Alan R. Yuen; Joanne Halsey; George A. Fisher; Jon T. Holmlund; Richard S. Geary; T. Jesse Kwoh; Andrew Dorr; Branimir I. Sikic

Abstract

View article

PDF

Vascular Endothelial Growth Factor Levels and Induction of Permeability in Malignant Pleural Effusions 1

Brian K. Zebrowski; Seiji Yano; Wenbiao Liu; Raymond M. Shaheen; Daniel J. Hicklin; Joe B. Putnam, Jr.; Lee M. Ellis

Abstract

View article

PDF

Clinical Trials

A Phase I and Pharmacological Study of Protracted Infusions of Crisnatol Mesylate in Patients with Solid Malignancies 1

Miguel A. Villalona-Calero; Thierry Petit; John Kuhn; Patrick Cobb; Maura Kraynak; S. Gail Eckhardt; Ronald Drengler; Cecelia Simmons; Pedro Santabarbara; Daniel D. Von Hoff; Eric K. Rowinsky

Abstract

View article

PDF

Coadministration of Oral Cyclosporin A Enables Oral Therapy with Paclitaxel

Jetske M. Meerum Terwogt; Mirte M. Malingré; Jos H. Beijnen; Wim W. ten Bokkel Huinink; Hilde Rosing; Franciska J. Koopman; Olaf van Tellingen; Martha Swart; Jan H. M. Schellens

Abstract

View article

PDF

Phase I and Imaging Trial of a Monoclonal Antibody Directed against Gastrin-releasing Peptide in Patients with Lung Cancer 1

Arvind Chaudhry; Jorge A. Carrasquillo; Ingalill L. Avis; Noriyuki Shuke; James C. Reynolds; Richard Bartholomew; Steven M. Larson; Frank Cuttitta; Bruce E. Johnson; James L. Mulshine

Abstract

View article

PDF

A Randomized Controlled Trial Comparing Intrathecal Sustained-release Cytarabine (DepoCyt) to Intrathecal Methotrexate in Patients with Neoplastic Meningitis from Solid Tumors 1

Michael J. Glantz; Kurt A. Jaeckle; Marc C. Chamberlain; Surasak Phuphanich; Lawrence Recht; Lode J. Swinnen; Bernard Maria; Susan LaFollette; G. Berry Schumann; Bernard F. Cole; Stephen B. Howell

Abstract

View article

PDF

Classification and Regression Tree Analysis of 1000 Consecutive Patients with Unknown Primary Carcinoma 1

Kenneth R. Hess; Marie C. Abbruzzese; Renato Lenzi; Martin N. Raber; James L. Abbruzzese

Abstract

View article

PDF

A Feasibility Study of Multiple Cycle Therapy with Melphalan, Thiotepa, and Paclitaxel followed by Mitoxantrone, Thiotepa, and Paclitaxel with Autologous Hematopoietic Cell Support for Metastatic Breast Cancer

Wendy W. Hu; Gwynn D. Long; Keith E. Stockerl-Goldstein; Laura J. Johnston; Nelson J. Chao; Robert S. Negrin; Karl G. Blume

Abstract

View article

PDF

A Phase I Study of Paclitaxel, Etoposide, and Cisplatin in Extensive Stage Small Cell Lung Cancer 1

Karen Kelly; Zhaoxing Pan; Marie E. Wood; James Murphy; Paul A. Bunn, Jr.

Abstract

View article

PDF

A Predictive Model for Relapse in High-Risk Primary Breast Cancer Patients Treated with High-Dose Chemotherapy and Autologous Stem-Cell Transplant

Yago Nieto; Pablo J. Cagnoni; Elizabeth J. Shpall; Xuesheng Xu; James Murphy; James Vredenburgh; Nelson J. Chao; Scott I. Bearman; Roy B. Jones

Abstract

View article

PDF

AIDS-related Kaposi’s Sarcoma: A Phase II Study of Liposomal Doxorubicin 1

Tony W. Cheung; Scot C. Remick; Nozar Azarnia; Jo Ann Proper; Jose R. Barrueco; Bruce J. Dezube; for the TLC d-99 Study Group

Abstract

View article

PDF

α-Difluoromethylornithine as Treatment for Metastatic Breast Cancer Patients

Joyce A. O’Shaughnessy; Laurence M. Demers; Stephen E. Jones; James Arseneau; Pankaj Khandelwal; Timothy George; Robert Gersh; David Mauger; Andrea Manni

Abstract

View article

PDF

Molecular Oncology, Markers, Clinical Correlates

Discovery of Differentially Expressed Genes Associated with Paclitaxel Resistance Using cDNA Array Technology: Analysis of Interleukin (IL) 6, IL-8, and Monocyte Chemotactic Protein 1 in the Paclitaxel-resistant Phenotype 1

Zhenfeng Duan; Aynn J. Feller; Richard T. Penson; Bruce. A. Chabner; Michael V. Seiden

Abstract

View article

PDF

Prospective Assessment of Allelic Losses at 4p14–16 in Colorectal Cancer: Two Mutational Patterns and a Locus Associated with Poorer Survival 1

Rosa Arribas; Maria Ribas; Rosa-Ana Risques; Laia Masramon; Silvia Tórtola; Eugenio Marcuello; Gemma Aiza; Rosa Miró; Gabriel Capellà; Miguel A. Peinado

Abstract

View article

PDF

Expression of Nuclear Receptor Interacting Proteins TIF-1, SUG-1, Receptor Interacting Protein 140, and Corepressor SMRT in Tamoxifen-resistant Breast Cancer

Christina M. W. Chan; Anne E. Lykkesfeldt; Malcolm G. Parker; Mitchell Dowsett

Abstract

View article

PDF

Aberrant Fragile Histidine Triad Gene Transcripts in Primary Hepatocellular Carcinoma and Liver Cirrhosis 1

Laura Gramantieri; Pasquale Chieco; Maddalena Di Tomaso; Livia Masi; Fabio Piscaglia; Stefano Brillanti; Stefano Gaiani; Marco Valgimigli; Alighieri Mazziotti; Luigi Bolondi

Abstract

View article

PDF

Allelic Loss in Esophageal Squamous Cell Carcinoma Patients with and without Family History of Upper Gastrointestinal Tract Cancer

Nan Hu; Mark J. Roth; Michael R. Emmert-Buck; Ze-Zhong Tang; Mihael Polymeropolous; Quan-Hong Wang; Alisa M. Goldstein; Xiao-You Han; Sanford M. Dawsey; Ti Ding; Carol Giffen; Philip R. Taylor

Abstract

View article

PDF

Immunohistochemical Expression of Somatostatin Type 2A Receptor in Neuroendocrine Tumors

Noriko Kimura; Monika Pilichowska; Fumiko Date; Itaru Kimura; Marcus Schindler

Abstract

View article

PDF

Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS 1

Peter T. Masiakos; David T. MacLaughlin; Shyamala Maheswaran; Jose Teixeira; Arlan F. Fuller, Jr.; Paresh C. Shah; David J. Kehas; Mary K. Kenneally; David M. Dombkowski; Thanh U. Ha; Frederic I. Preffer; Patricia K. Donahoe

Abstract

View article

PDF

TP53 Accumulation Predicts Improved Survival in Patients Resistant to Systemic Cisplatin-based Chemotherapy forMuscle-invasive Bladder Cancer 1

K. N. Qureshi; T. R. L. Griffiths; M. C. Robinson; C. Marsh; J. T. Roberts; R. R. Hall; J. Lunec; D. E. Neal

Abstract

View article

PDF

Apoptosis and Expression of Apoptosis Regulating Proteins bcl-2, mcl-1, bcl-X, and bax in Malignant Mesothelioma 1

Ylermi Soini; Vuokko Kinnula; Riitta Kaarteenaho-Wiik; Esko Kurttila; Kaija Linnainmaa; Paavo Pääkkö

Abstract

View article

PDF

Different Patterns of Angiogenesis in Sarcomas and Carcinomas 1

James Tomlinson; Sanford H. Barsky; Scott Nelson; Samuel Singer; Behnaz Pezeshki; Maggie C. Lee; Frederick Eilber; Mai Nguyen

Abstract

View article

PDF

Characterization of p53 Mutations in Colorectal Liver Metastases and Correlation with Clinical Parameters 1

Appolonia Tullo; Anna M. D’Erchia; Kazuo Honda; Ragai R. Mitry; Michael D. Kelly; Nagy A. Habib; Cecilia Saccone; Elisabetta Sbisà

Abstract

View article

PDF

Circulating Soluble Fas Concentration in Breast Cancer Patients

Takayuki Ueno; Masakazu Toi; Takeshi Tominaga

Abstract

View article

PDF

Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma

Nicole L. W. Van Hal; Guus A. M. S. Van Dongen; Corlinda B. M. Ten Brink; Karl-Heinz Heider; Irene Rech-Weichselbraun; Gordon B. Snow; Ruud H. Brakenhoff

Abstract

View article

PDF

Importance of Nuclear Morphology in Breast Cancer Prognosis

William H. Wolberg; W. Nick Street; Olvi L. Mangasarian

Abstract

View article

PDF

Genetically Fluorescent Melanoma Bone and Organ Metastasis Models 1

Meng Yang; Ping Jiang; Zili An; Eugene Baranov; Lingna Li; Satoshi Hasegawa; Maraya Al-Tuwaijri; Takashi Chishima; Hiroshi Shimada; A. R. Moossa; Robert M. Hoffman

Abstract

View article

PDF

Five Novel Immunogenic Antigens in Meningioma: Cloning, Expression Analysis, and Chromosomal Mapping 1

Nicole Comtesse; Dirk Heckel; Alexander Rácz; Nicole Brass; Brenda Glass; Eckart Meese

Abstract

View article

PDF

Deletion of Chromosome 1p and Loss of Expression of Alkaline Phosphatase Indicate Progression of Meningiomas

Patrick Müller; Wolfram Henn; Isolde Niedermayer; Ralf Ketter; Wolfgang Feiden; Wolf-Ingo Steudel; Klaus D. Zang; Heike Steilen-Gimbel

Abstract

View article

PDF

Androgen Receptor Gene Alterations and Chromosomal Gains and Losses in Prostate Carcinomas Appearing During Finasteride Treatment for Benign Prostatic Hyperplasia 1

Pasi A. Koivisto; Johanna Schleutker; Heikki Helin; Conny Ehren-van Eekelen; Olli-Pekka Kallioniemi; Jan Trapman

Abstract

View article

PDF

Experimental Therapeutics, Preclinical Pharmacology

A Human Prolactin Antagonist, hPRL-G129R, Inhibits Breast Cancer Cell Proliferation through Induction of Apoptosis 1

Wen Y. Chen; Preveen Ramamoorthy; Nian-yi Chen; Robert Sticca; Thomas E. Wagner

Abstract

View article

PDF

Antitumor Activity of CEP-751 (KT-6587) on Human Neuroblastoma and Medulloblastoma Xenografts 1

Audrey E. Evans; Kristin D. Kisselbach; Darrell J. Yamashiro; Naohiko Ikegaki; Anna Marie Camoratto; Craig A. Dionne; Garrett M. Brodeur

Abstract

View article

PDF

BAY 12-9566, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity 1

Carmen Gatto; Monica Rieppi; Patrizia Borsotti; Silvia Innocenti; Roberta Ceruti; Teresa Drudis; Eugenio Scanziani; Anna M. Casazza; Giulia Taraboletti; Raffaella Giavazzi

Abstract

View article

PDF

Radiotherapy and Dosimetry of ⁶⁴Cu-TETA-Tyr³-Octreotate in a Somatostatin Receptor-positive, Tumor-bearing Rat Model 1

Jason S. Lewis; Michael R. Lewis; P. Duffy Cutler; Ananth Srinivasan; Michelle A. Schmidt; Sally W. Schwarz; Margaret M. Morris; J. Philip Miller; Carolyn J. Anderson

Abstract

View article

PDF

Synergy of Topotecan in Combination with Vincristine for Treatment of Pediatric Solid Tumor Xenografts 1

Joyce Thompson; E. Olusegun George; Catherine A. Poquette; Pamela J. Cheshire; Lois B. Richmond; Siebold S. N. de Graaf; Margaret Ma; Clinton F. Stewart; Peter J. Houghton

Abstract

View article

PDF

Enhanced Antitumor Activity of Paclitaxel in Combination with the Anticarcinoma Immunoconjugate BR96-Doxorubicin

Pamela A. Trail; David Willner; Albert B. Bianchi; Arris J. Henderson; Mark D. TrailSmith; Emel Girit; Shirley Lasch; Ingegerd Hellström; Karl Erik Hellström

Abstract

View article

PDF

A Cell Type-specific and Gap Junction-independent Mechanism for the Herpes Simplex Virus-1 Thymidine Kinase Gene/Ganciclovir-mediated Bystander Effect 1

Frédéric Princen; Pierre Robe; Chantal Lechanteur; Marc Mesnil; Jean-Michel Rigo; Jacques Gielen; Marie-Paule Merville; Vincent Bours

Abstract

View article

PDF

Direct Comparison of Liposomal Doxorubicin with or without Polyethylene Glycol Coating in C-26 Tumor-bearing Mice: Is Surface Coating with Polyethylene Glycol Beneficial?1

Ruey-Long Hong; Chang-Jen Huang; Yun-Long Tseng; Victor Fei Pang; Shui-Tsung Chen; Jun-Jen Liu; Fu-Hsiung Chang

Abstract

View article

PDF

The Outcome of Heregulin-induced Activation of Ovarian Cancer Cells Depends on the Relative Levels of HER-2 and HER-3 Expression 1

Fengji Xu; Yinhua Yu; Xiao-Feng Le; Cinda Boyer; Gordon B. Mills; Robert C. Bast, Jr.

Abstract

View article

PDF

Expression of Bisecting GlcNAc in Pediatric Brain Tumors and Its Association with Tumor Cell Response to Vinblastine 1

Abdelhadi Rebbaa; Pauline M. Chou; Ivica Vucic; Bernard L. Mirkin; Tadanori Tomita; Eric G. Bremer

Abstract

View article

PDF

The Antiangiogenic Agent Linomide Inhibits the Growth Rate of von Hippel-Lindau Paraganglioma Xenografts to Mice

David J. Gross; Israel Reibstein; Lola Weiss; Shimon Slavin; Ilan Stein; Michal Neeman; Rinat Abramovitch; Laura E. Benjamin

Abstract

View article

PDF

Eradication of Human Medulloblastoma Tumor Xenografts with a Combination of O⁶-Benzyl-2′-deoxyguanosine and 1,3-Bis(2-chloroethyl)-1-nitrosourea 1

Demetrius M. Kokkinakis; Robert C. Moschel; Anthony E. Pegg; S. Clifford Schold

Abstract

View article

PDF

Pharmacokinetics of PK1 and Doxorubicin in Experimental Colon Tumor Models with Differing Responses to PK1 1

Paul M. Loadman; Mike C. Bibby; John A. Double; Waleed M. Al-Shakhaa; Ruth Duncan

Abstract

View article

PDF

Simplified Production of a Recombinant Human Angiostatin Derivative That Suppresses Intracerebral Glial Tumor Growth 1

Patricio I. Meneses; Lauren E. Abrey; Katherine A. Hajjar; S. Humayun Gultekin; Robert M. Duvoisin; Kenneth I. Berns; Myrna R. Rosenfeld

Abstract

View article

PDF

Cancer Biology, Immunology, Cytokines

Antagonistic Effect of NK4, a Novel Hepatocyte Growth Factor Variant, on in Vitro Angiogenesis of Human Vascular Endothelial Cells 1

Wen G. Jiang; Steve E. Hiscox; Christian Parr; Tracey A. Martin; Kunio Matsumoto; Toshikazu Nakamura; Robert E. Mansel

Abstract

View article

PDF

Lysophosphatidic Acid Induces Urokinase Secretion by Ovarian Cancer Cells 1

Terri B. Pustilnik; Veronica Estrella; Jon R. Wiener; Muling Mao; Astrid Eder; Mary-Anne V. Watt; Robert C. Bast, Jr.; Gordon B. Mills

Abstract

View article

PDF

Constitutive and Inducible Interleukin 8 Expression by Hypoxia and Acidosis Renders Human Pancreatic Cancer Cells More Tumorigenic and Metastatic 1

Qian Shi; James L. Abbruzzese; Suyun Huang; Isaiah J. Fidler; Qinghua Xiong; Keping Xie

Abstract

View article

PDF

Letters to the Editor

Correspondence 1 re: S. Shimoyama et al., Increased Serum Angiogenin Concentration in Colorectal Cancer Is Correlated with Cancer Progression. Clin. Cancer Res., 5: 1125–1130, 1999.

Sagrario Montero; Belén Lloveras; Hernán Cortés-Funes; Ramon Colomer

Extract

View article

PDF

Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287–294, 1998.

Paula Soares; Manuel Sobrinho-Simões

Extract

View article

PDF

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

Characterization of Cell-free DNA Size Distribution in Osteosarcoma Patients

Single-cell transcriptomics reveals immune reconstitution in R/R T-ALL/LBL patients with donor-derived CD7 CAR-T therapy

The oral PI3Kδ inhibitor linperlisib for the treatment of relapsed and/or refractory follicular lymphoma: A phase 2, single-arm, open-label clinical trial

Issues

Editorials

Advances in Brief

Phase I Study of an Antisense Oligonucleotide to Protein Kinase C-α (ISIS 3521/CGP 64128A1) in Patients with Cancer2

Clinical Trials

Molecular Oncology, Markers, Clinical Correlates

Experimental Therapeutics, Preclinical Pharmacology

Cancer Biology, Immunology, Cytokines

Letters to the Editor

Correspondence1 re: S. Shimoyama et al., Increased Serum Angiogenin Concentration in Colorectal Cancer Is Correlated with Cancer Progression. Clin. Cancer Res., 5: 1125–1130, 1999.

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Phase I Study of an Antisense Oligonucleotide to Protein Kinase C-α (ISIS 3521/CGP 64128A 1) in Patients with Cancer²

Correspondence 1 re: S. Shimoyama et al., Increased Serum Angiogenin Concentration in Colorectal Cancer Is Correlated with Cancer Progression. Clin. Cancer Res., 5: 1125–1130, 1999.